David E. Clements
9Patents
4h-index
11Co-inventors
54Inventor score
Filing activity: Aug 30, 1993 → Jul 26, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6165477A | Subunit immonogenic composition against dengue infection | Emerging Cross-Sectional Technologies | 42 | Expired |
| US6136561A | Methods of preparing carboxy-terminally truncated recombinant flavivirus envelope glycoproteins employing drosophila melanogaster expression systems | Emerging Cross-Sectional Technologies | 27 | Expired |
| US6432411B1 | Recombinant envelope vaccine against flavivirus infection | Emerging Cross-Sectional Technologies | 19 | Expired |
| US6329191A | DNA encoding recombinant coffee bean alpha-galactosidase | Chemistry; Metallurgy | 5 | Expired |
| US6682909B2 | Immunogenic composition of hepatitis C and methods of use thereof | Chemistry; Metallurgy | 3 | Expired |
| US8198079B2 | Synthetic expression vectors for insect cells | Chemistry; Metallurgy | 1 | Active |
| US7947286B2 | Drosophila cell lines producing recombinant secretable filovirus surface glycoproteins lacking the membrane spanning domain | Chemistry; Metallurgy | 0 | Active |
| US11434261B2 | Optimized Zika virus envelope gene and expression thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US11135281B2 | West nile virus vaccine and method of use thereof | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.